a study of women with chest pain and normal coronary angiograms
Raffaele Bugiardini 1, Olivia Manfrini, Carmine Pizzi, Fiorella Fontana, Gianluigi Morgagni
Affiliations expand
PMID: 15136498
DOI: 10.1161/01.CIR.0000128208.22378.E3
Abstract Background: The prognosis for women with chest pain and angiographically normal coronary arteries is believed to be totally benign. Previous studies, however, did not account for the delay of a decade or so in the development of coronary artery disease that women may experience. Methods and results: This study assessed long-term follow-up of 42 women with de novo angina, evidence of reversible myocardial perfusion defects on SPECT, and normal coronary angiograms. At recruitment, all women underwent endothelial function testing (intracoronary acetylcholine) during catheterization. Patients were followed up for >10 years. Angiography was repeated at the end of the follow-up in 37 patients. At recruitment, 22 patients developed diffuse vasoconstriction during acetylcholine in the absence of identifiable focal coronary spasm (acetylcholine-positive group). The remaining 20 patients showed vasodilation (acetylcholine-negative group). At the end of follow-up, in the acetylcholine-positive group, 1 patient developed cardiac death, 13 still complained of chest pain, and 8 had remission of symptoms. In the acetylcholine-negative group, all patients showed complete resolution of chest pain beginning 6 to 36 months after baseline assessment. Angiography showed development of coronary artery disease in the 13 symptomatic patients in the acetylcholine-positive group. Conclusions: In women with angiographically normal-appearing coronary arteries, persistence of chest pain over the years often relates to development of coronary artery disease. Endothelial dysfunction in a setting of normal coronary arteries is a sign of future development of atherosclerosis.
Similar articles
Microvascular coronary artery spasm presents distinctive clinical features with endothelial dysfunction as nonobstructive coronary artery disease.Ohba K, Sugiyama S, Sumida H, Nozaki T, Matsubara J, Matsuzawa Y, Konishi M, Akiyama E, Kurokawa H, Maeda H, Sugamura K, Nagayoshi Y, Morihisa K, Sakamoto K, Tsujita K, Yamamoto E, Yamamuro M, Kojima S, Kaikita K, Tayama S, Hokimoto S, Matsui K, Sakamoto T, Ogawa H.J Am Heart Assoc. 2012 Oct;1(5):e002485. doi: 10.1161/JAHA.112.002485. Epub 2012 Oct 25.PMID: 23316292 Free PMC article. Clinical Trial.
Evidence of impaired endothelium-dependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms.Egashira K, Inou T, Hirooka Y, Yamada A, Urabe Y, Takeshita A.N Engl J Med. 1993 Jun 10;328(23):1659-64. doi: 10.1056/NEJM199306103282302.PMID: 8487824
Comparison of effect between nitrates and calcium channel antagonist on vascular function in patients with normal or mildly diseased coronary arteries.Ninomiya Y, Hamasaki S, Saihara K, Ishida S, Kataoka T, Ogawa M, Orihara K, Oketani N, Fukudome T, Okui H, Ichiki T, Shinsato T, Kubozono T, Mizoguchi E, Ichiki H, Tei C.Heart Vessels. 2008 Mar;23(2):83-90. doi: 10.1007/s00380-007-1019-4. Epub 2008 Apr 4.PMID: 18389331 Clinical Trial.
Prognostic value of an abnormal response to acetylcholine in patients with angina and non-obstructive coronary artery disease: Long-term follow-up of the Heart Quest cohort.Schoenenberger AW, Adler E, Gujer S, Jamshidi P, Kobza R, Stuck AE, Resink TJ, Erne P.Int J Cardiol. 2016 Oct 15;221:539-45. doi: 10.1016/j.ijcard.2016.07.035. Epub 2016 Jul 6.PMID: 27414736 Clinical Trial.
Impaired endothelium-dependent cholinergic coronary vasodilation in patients with angina and normal coronary arteriograms.Vrints CJ, Bult H, Hitter E, Herman AG, Snoeck JP.J Am Coll Cardiol. 1992 Jan;19(1):21-31. doi: 10.1016/0735-1097(92)90046-p.PMID: 1729336
Comments